Thromboangiitis obliterans is a rare disease that inflames and blocks small and medium blood vessels in the hands and feet. It mostly affects people who smoke or use other tobacco or nicotine products, often before age 45.
Early symptoms of thromboangiitis obliterans can include finger or toe pain, burning, numbness, cold sensitivity, and color changes in the skin. Thromboangiitis obliterans usually lasts for years and can get worse over time if tobacco or nicotine use continues. Not everyone will have the same experience, but the main treatment for thromboangiitis obliterans is stopping all tobacco and nicotine, and severe cases can lead to ulcers, tissue loss, or amputation, while death from the condition itself is uncommon.
How many people live with Thromboangiitis obliterans?
Worldwide, there is no single official head count for thromboangiitis obliterans, but rare-disease sources suggest it affects about 1 to 9 out of every 100,000 people overall, which suggests roughly 80,000 to 730,000 people worldwide; the wide range is because it is much more common in some places than others and because doctors do not all count cases the same way (Orphanet, 2024). In the United States, widely cited estimates suggest about 8 to 12.6 out of every 100,000 people are living with it, or roughly 27,000 to 42,000 people (StatPearls, 2023).
Overview
Thromboangiitis obliteransSymptoms
Thromboangiitis obliterans often causes burning pain in the hands or feet, especially with walking or in the cold. Fingers or toes may look pale, bluish, or red, and sores can develop. Early symptoms of thromboangiitis obliterans can come and go.
Outlook and prognosis
For many living with thromboangiitis obliterans, the outlook depends heavily on stopping all tobacco and nicotine exposure. If that happens early, pain often eases and tissue loss may be prevented; if not, ulcers, gangrene, and amputation become much more likely.
Causes and risk factors
Thromboangiitis obliterans is strongly linked to smoking or other tobacco and nicotine use, including chewing tobacco. Risk is higher in younger adults, especially men, and may reflect a mix of inflammation, genetic susceptibility, and sometimes cannabis use.
Genetic influences
Genetics do not seem to be a main cause of thromboangiitis obliterans. Some inherited differences may slightly affect risk, but smoking and tobacco exposure are far more important. Family patterns are uncommon, and there is no single known gene test for thromboangiitis obliterans.
Diagnosis
Thromboangiitis obliterans is diagnosed from symptoms, an exam, and a careful smoking history. There is no single test, so doctors rule out other causes of poor blood flow. Imaging of blood vessels can support the diagnosis of thromboangiitis obliterans.
Treatment and drugs
For people with thromboangiitis obliterans, stopping all tobacco and nicotine is the key treatment because it can slow or stop further vessel damage. Care may also include pain relief, wound care, and treatment to improve blood flow.
Symptoms
Pain in the feet, hands, fingers, or toes is often what first disrupts daily life with thromboangiitis obliterans. The changes are often subtle at first, blending into daily life until they become more noticeable. Many people notice cramping with walking or using their hands in the cold, then more persistent discomfort, color changes, or sores that heal poorly. The early symptoms of thromboangiitis obliterans can overlap with other circulation problems, so a medical evaluation is important.
Cramping, aching, or burning pain can start in the foot, calf, hand, or forearm during walking or repeated use and ease with rest. Day to day, it can feel like a short walk or simple chore suddenly brings on tight, uncomfortable pain.
As blood flow worsens, pain may happen even while sitting or lying down, especially in the fingers, toes, feet, or hands. Some people with thromboangiitis obliterans find it is worse at night or when the limb is raised.
Fingers or toes may turn pale, bluish, or reddish and feel unusually cold, especially in cold weather or during stress. Many living with thromboangiitis obliterans notice that warming the area takes longer than it used to.
Poor circulation can cause pins and needles, numb patches, or a prickly feeling in the affected areas. What once felt effortless can start to require more energy or focus, like buttoning a shirt or walking across a parking lot.
How people usually first notice Thromboangiitis obliterans?
Thromboangiitis obliterans is often first noticed when a person who smokes or uses other tobacco products starts having pain, burning, or cramping in the feet, toes, hands, or fingers, especially during walking or in cold weather. Many living with this condition also notice that their fingers or toes become unusually cold, pale, bluish, or numb, and some first signs of thromboangiitis obliterans are small painful sores on the tips of the fingers or toes that do not heal well. Because these early changes can look like poor circulation from other causes, the pattern that often stands out is pain and color changes in the small blood vessels of the hands and feet in someone with a strong history of tobacco exposure.
Types of Thromboangiitis obliterans
Thromboangiitis obliterans does not have formal disease subtypes, but its symptoms often vary based on which blood vessels are affected and how much blood flow is reduced. Symptoms don’t always look the same for everyone. For many living with thromboangiitis obliterans, this can mean pain in the hands or feet, color changes, or sores that are slow to heal. Early symptoms of thromboangiitis obliterans are often easy to mistake for circulation problems from other causes.
Limb pain
Many people with thromboangiitis obliterans notice aching, cramping, or burning pain in the feet, lower legs, hands, or forearms. The pain often starts with walking or using the hands and may later happen even at rest.
Color changes
Fingers or toes may turn pale, bluish, or reddish when exposed to cold or stress. Some may also find that the affected areas feel unusually cold or numb.
Sores and ulcers
Reduced blood flow can lead to painful sores on the fingers, toes, or nearby skin that heal slowly. In more severe cases, tissue damage can develop if circulation stays very limited.
Vein inflammation
Some people develop tender, red areas along a vein just under the skin, especially in the hands or feet. This can come and go and may appear before or alongside other symptoms of thromboangiitis obliterans.
Can I slow down the onset of symptoms?
Yes, but mainly in one very important way: for thromboangiitis obliterans, also called Buerger disease, completely stopping all tobacco and nicotine exposure is the only well-established step linked to delaying symptoms or keeping the disease from getting worse. This can lower the chance of symptoms and slow damage to blood vessels, but it does not guarantee prevention; simply cutting back is usually not enough, and there is little solid proof that diet, exercise, sleep, or supplements can delay onset on their own. Regular care with a doctor who treats blood flow problems can help catch changes early, and if quitting feels hard, getting support is still the most meaningful step you can take.
What genetics can tell you about symptoms
For people living with thromboangiitis obliterans, also called Buerger disease, genetics may play a small role in who is more likely to develop the condition, but it does not clearly predict exactly which symptoms someone will have. At this point, there is no well-established gene change that reliably tells doctors whether symptoms will start earlier, become more severe, or affect the hands more than the feet. In day-to-day care, smoking and tobacco exposure remain far more important than genetics for how this disease shows up and how it progresses.
Causes and risk factors
If you are wondering what causes thromboangiitis obliterans, tobacco exposure is the strongest known trigger. Smoking and chewing tobacco are the main risks, and secondhand smoke may also add to risk. Some people may have a genetic tendency, and family history can play a part. It is rarely just one factor, and the mix matters. Thromboangiitis obliterans is seen more often in younger adults and in men, although women can develop it too.
What are the most common causes or risk factors?
The exact cause of thromboangiitis obliterans, also called Buerger disease, is not fully understood, but the biggest risk factor by far is using tobacco in any form, especially heavy cigarette smoking. It is most common in younger adults, often under age 45, and has been seen more often in men, although women can get it too. There is no single proven inherited cause, but some people may have inherited traits that make their blood vessels more likely to become inflamed after tobacco exposure.
Environmental and biological risk factors
The main risk factors for thromboangiitis obliterans are not all equal, and tobacco or nicotine exposure stands out far above the rest. Doctors often group risks into internal (biological) and external (environmental). Age, sex pattern, and the way the body reacts to nicotine also seem to shape who is more likely to develop this condition.
This is the strongest known risk factor for thromboangiitis obliterans. Cigarettes, cigars, pipes, and smokeless tobacco are all linked to the disease. Even small ongoing exposure can keep the harmful vessel inflammation active.
Nicotine itself appears to play an important role, not just the smoke around it. That is why nicotine-containing products, including some vaping products or nicotine replacement products, may still be a concern in people at risk.
This condition most often starts before age 45. It is much less common for it to first appear later in life.
Thromboangiitis obliterans has historically been diagnosed more often in men than in women. The difference is smaller in places where tobacco exposure has become more common among women.
Genetic risk factors
When doctors study the genetic risk factors for thromboangiitis obliterans, they find a pattern of inherited susceptibility rather than one clear genetic cause. No single gene change has been proven to directly cause thromboangiitis obliterans, although inherited differences in immune function may affect risk. Carrying certain risks doesn’t automatically lead to thromboangiitis obliterans, and many living with it have no known family history.
No single gene: No single inherited gene change has been confirmed as the cause of thromboangiitis obliterans. This means routine genetic testing is not usually used to diagnose it or rule it out.
Family history: A family history of thromboangiitis obliterans can raise suspicion that inherited factors are playing a part. Even so, the condition does not usually show a clear parent-to-child pattern.
Immune markers: Certain inherited immune-system markers have been linked with higher rates of thromboangiitis obliterans in some populations. These findings suggest genes that shape inflammation and blood-vessel reactions may influence risk, but they do not reliably predict who will develop the disease.
Complex inheritance: Researchers believe several genes may each add a small amount to risk rather than one gene acting alone. This helps explain why people with similar backgrounds can still have very different experiences.
Lifestyle risk factors
For thromboangiitis obliterans, the most important lifestyle risk factor by far is tobacco and nicotine exposure. In practice, how lifestyle affects thromboangiitis obliterans is mainly through ongoing vessel inflammation, reduced blood flow, worse pain, and a higher risk of ulcers or amputation. Other habits matter mostly because they can trigger poor circulation or make ischemic injury harder to heal.
Smoking is the strongest lifestyle driver of thromboangiitis obliterans and can keep the disease active. Even low daily use can worsen vessel inflammation, reduce blood flow to fingers and toes, and increase the risk of ulcers, gangrene, and amputation.
Chewing tobacco and snuff can still expose the body to nicotine and may continue disease activity. Switching from cigarettes to smokeless products does not reliably protect against progression.
E-cigarettes, nicotine pouches, and other nicotine products may still constrict blood vessels and may aggravate thromboangiitis obliterans. For many patients, complete nicotine avoidance is a key part of reducing ongoing ischemia.
Smoking cannabis can irritate and constrict blood vessels and may worsen symptoms in some people with thromboangiitis obliterans. If tobacco is mixed with cannabis, the risk is even more concerning.
Risk prevention
For thromboangiitis obliterans, the single most important way to prevent the disease or keep it from getting worse is to avoid all tobacco and nicotine. This condition is very strongly linked to smoking and other nicotine exposure, and in many people the disease keeps progressing unless that exposure stops completely. Prevention is about lowering risk, not eliminating it completely, and with thromboangiitis obliterans that usually means removing triggers and protecting blood flow to the hands and feet.
Not starting smoking is the clearest way to lower the risk of thromboangiitis obliterans. If you already smoke, stopping completely is far more protective than simply cutting down. Cigarettes, cigars, pipes, and smokeless tobacco can all matter.
Many living with thromboangiitis obliterans need to avoid nicotine in every form, including vaping products and nicotine pouches. Even small ongoing exposure may continue to irritate blood vessels and raise the risk of blocked circulation.
Cannabis use has also been linked to thromboangiitis obliterans in some people. Avoiding it may help lower the chance of disease activity, especially when it is smoked.
Secondhand smoke may still expose your body to nicotine and other vessel-damaging chemicals. Keeping your home, car, and work spaces smoke-free can support prevention and protect healing.
Can you prevent Thromboangiitis obliterans?
You cannot always prevent thromboangiitis obliterans completely, but the most proven way to lower the risk is to avoid tobacco in all forms. This disease is very strongly linked to smoking and other tobacco use, so not starting, or quitting fully if you do use it, matters most. If someone already has it, stopping all tobacco is also the best-known step to help keep it from getting worse.
Transmission
Thromboangiitis obliterans is not contagious, so it does not spread from one person to another through touch, kissing, sex, coughs, or shared food and drinks. If you are wondering whether Thromboangiitis obliterans can be transferred, the short answer is no: it is not an infection and is not considered infectious at any stage.
Instead, Thromboangiitis obliterans is closely linked to tobacco and nicotine exposure, and that is the main reason it develops and keeps flaring. Many living with Thromboangiitis obliterans ask how it is inherited, but it is not usually passed down in a clear parent-to-child pattern, even though genes may affect who is more vulnerable.
When to test your genes
For thromboangiitis obliterans, genetic testing is not part of routine early detection or treatment planning. Diagnosis and care are guided by symptoms, blood flow testing, and, above all, tobacco exposure, since stopping all nicotine is the most important step.
Diagnosis
Thromboangiitis obliterans is usually suspected when blood flow problems start affecting the hands or feet, often in someone who smokes or uses other tobacco products. You might notice small changes in daily routines, like finger pain in the cold, foot pain when walking, or sores that are slow to heal. The diagnosis of thromboangiitis obliterans is based on symptoms, the pattern of poor circulation, and tests that help rule out other causes of blocked blood vessels.
Doctors usually begin by asking about tobacco use, symptoms in the fingers, toes, hands, or feet, and whether pain happens at rest or with activity. A detailed family and health history can help separate thromboangiitis obliterans from diabetes, autoimmune disease, and hardening of the arteries.
The exam checks pulses, skin color, temperature, ulcers, and signs of reduced blood flow in the arms or legs. Your provider may also look for tenderness along veins or changes that suggest repeated inflammation and clotting in small and medium blood vessels.
Blood tests do not confirm thromboangiitis obliterans on their own, but they are important for ruling out more common causes of poor circulation. These and other lab tests may help rule out diabetes, autoimmune conditions, clotting disorders, and infections.
Doctors may perform blood pressure and blood flow tests in the fingers, toes, arms, and legs to see how much circulation is reduced. These exams can show a pattern of distal vessel disease, meaning the blockage is farther out in the limbs rather than in the body's larger central arteries.
How is Thromboangiitis obliterans diagnosed?
Thromboangiitis obliterans, often called Buerger disease, is usually diagnosed from the pattern of symptoms, a history of current or past tobacco use, and an exam showing poor blood flow to the fingers, toes, hands, or feet. Doctors also use blood tests and blood flow scans, such as ultrasound or a dye test that shows the blood vessels, to rule out other causes like diabetes, immune system disease, blood clots, or artery narrowing from plaque buildup. There is no single test, and routine genetic testing is not part of diagnosis, so doctors make the diagnosis by putting all of these findings together.
Stages of Thromboangiitis obliterans
Thromboangiitis obliterans does not have defined progression stages. This is because it usually does not follow a set step-by-step pattern, and symptoms can flare, improve, or worsen depending on blood flow and whether someone continues to use tobacco. Doctors usually start with a conversation about early symptoms of thromboangiitis obliterans, such as finger or toe pain, cold sensitivity, color changes, or sores that heal slowly, along with an exam of the hands and feet. It is usually monitored by checking symptoms over time and using blood flow tests, imaging, and other tests to rule out more common causes of blocked arteries.
Outlook and prognosis
The outlook for thromboangiitis obliterans varies widely and depends most on complete tobacco and nicotine cessation, because continued smoking is strongly linked to ongoing vessel inflammation, recurrent pain, ulcers, and tissue loss. If a person stops all tobacco exposure early, symptoms may stabilize and the risk of major complications can drop substantially, although existing vessel damage may not fully reverse. People who continue to smoke often face repeated episodes of reduced blood flow, chronic ischemic pain, nonhealing wounds, and a much higher likelihood of finger, toe, or limb amputation. Mortality is usually not driven directly by the disease itself, and overall survival can be relatively good, but severe disability and loss of function are important long-term risks. Prognosis is generally worse in those with advanced ischemia, infection, or delayed diagnosis and treatment.
Long-term effects
Thromboangiitis obliterans can have lasting effects on comfort, movement, and in severe cases, the health of fingers, toes, hands, or feet. Many living with thromboangiitis obliterans find that pain with walking, cold sensitivity, or slow-healing sores can interfere with work, errands, and sleep. Long-term effects vary widely, but ongoing reduced blood flow is the main reason problems can build over time.
Burning pain, aching at rest, or cramping with walking can continue over the long term when blood flow stays limited. Some may find that even short trips, standing for long periods, or being out in cold weather become harder than before.
Small cuts or blisters on the fingers or toes may heal very slowly and can turn into painful open sores. This can make everyday things like wearing shoes, typing, or buttoning clothes more difficult.
If circulation drops further, skin and deeper tissue may begin to break down and die, which is called gangrene. In medical terms, these are sometimes called late effects or chronic symptoms.
Open sores and damaged tissue raise the chance of infection, especially in the feet or hands. Infection can worsen pain, delay healing, and sometimes spread into deeper tissue.
How is it to live with Thromboangiitis obliterans?
Living with thromboangiitis obliterans can mean planning your day around pain, numbness, or cold fingers and toes, especially with walking or in cool weather, and for some people even small wounds on the hands or feet can become slow to heal and hard to ignore. Daily life often changes in very practical ways: protecting the limbs from cold and injury, limiting activities when pain flares, and making complete nicotine avoidance the center of treatment, because even small exposures can keep the disease active. This can also affect the people around you, since family and friends may need to help with mobility, wound care, and creating a smoke-free environment, but those shared changes can make a real difference in protecting blood flow and preserving independence.
Treatment and drugs
Thromboangiitis obliterans is treated mainly by stopping all tobacco and nicotine exposure, because even a small amount can keep the blood vessel inflammation active and make pain, sores, or poor circulation in the fingers and toes worse. Support from family or friends can make daily treatment easier, since quitting smoking or vaping is the most important step and often the hardest one. Doctors may also use medicines to improve blood flow, ease pain, help skin ulcers heal, and lower the chance of infection, but these drugs usually help symptoms more than they cure the disease itself. If thromboangiitis obliterans is severe or early symptoms of thromboangiitis obliterans are getting worse, treatment may include wound care, hospital treatment for serious loss of blood flow, and sometimes procedures such as removing damaged tissue or, rarely, amputation when tissue cannot be saved.
Can you cure Thromboangiitis obliterans?
No, thromboangiitis obliterans, also called Buerger disease, does not currently have a cure. The most important treatment is stopping all tobacco and nicotine completely, because this can keep the disease from getting worse and lower the risk of serious damage to the hands, feet, and skin. Other treatments may help ease pain, improve blood flow, and help sores heal, but they cannot reverse damage that has already happened.
Non-drug treatment
Treatment often centers on protecting blood flow to the fingers, toes, hands, and feet so pain and sores are less likely to worsen. Managing this condition often starts with completely stopping all tobacco and nicotine exposure, because even small amounts can keep the disease active. Many living with thromboangiitis obliterans also benefit from careful skin and foot care, staying warm, and working with specialists on exercise, wound care, and daily function. If tissue damage is severe, rehabilitation support and procedures to remove damaged tissue may become part of care.
Completely stopping cigarettes, cigars, smokeless tobacco, vaping, and all nicotine products is the most important non-drug treatment for thromboangiitis obliterans. Ongoing counseling, quit programs, and behavior support can make quitting more likely to last.
Keeping hands and feet warm can help reduce vessel spasm and improve comfort in cold weather or air-conditioned spaces. Warm socks, gloves, and avoiding sudden temperature changes can be especially helpful if fingers or toes change color or become painful.
Daily foot care for thromboangiitis obliterans can lower the chance of cuts, ulcers, and infections that heal slowly. Checking the skin each day, wearing well-fitting shoes, and treating even small blisters early can make a real difference.
Regular wound care helps protect ulcers or damaged skin and supports healing as much as possible. This may include cleaning, dressings, pressure relief, and specialist care if an area looks infected, turns black, or becomes more painful.
Your genes may have an impact on how drugs work for you
For people living with thromboangiitis obliterans, also called Buerger disease, there is no well-established genetic test that helps predict how the usual medicines for pain, blood flow, or clot prevention will work. In day-to-day care, response to treatment is driven much more by whether tobacco exposure fully stops, how severe the blocked blood vessels are, and whether sores or infections are present. Researchers are still studying whether inherited differences play a part, but right now genetics is not a routine guide for medication choices in this condition.
Pharmacological treatments
For many living with thromboangiitis obliterans, medicines are mainly used to ease pain, improve blood flow, and help wounds heal, rather than cure the disease itself. The drug with the best evidence for severe symptoms is iloprost, especially when pain at rest or finger and toe ulcers are present. Other medicines may be added for comfort or specific problems, but stopping all tobacco and nicotine remains the most important treatment step. Not everyone responds to the same medication in the same way.
Iloprost is a vessel-opening medicine often given by vein in the hospital when thromboangiitis obliterans is causing severe pain, poor circulation, or sores on fingers or toes. It can improve blood flow and may lower the chance of amputation in some people with advanced disease.
Pain medicines such as acetaminophen or anti-inflammatory drugs may help milder discomfort, while stronger prescription pain drugs are sometimes needed for ongoing ischemic pain. For many, this can mean getting through walking, sleeping, or dressing changes with less distress.
Aspirin or clopidogrel may be used to reduce platelet clumping and to support overall circulation care, although they do not stop thromboangiitis obliterans from progressing on their own. They are often considered when there is a high risk of clot-related complications or after vascular procedures.
Medicines that widen blood vessels, such as calcium channel blockers like nifedipine, may help if cold sensitivity or blood vessel spasm is making hand or foot symptoms worse. Some medicines work quickly, while others are mainly used to reduce day-to-day attacks rather than treat blocked arteries directly.
Genetic influences
Smoking and other tobacco or nicotine exposure are the main drivers of thromboangiitis obliterans, but genes may help explain why only some people develop it. It’s natural to ask whether family history plays a role. Right now, doctors do not view thromboangiitis obliterans as a clearly inherited disorder, and no single gene change has been shown to cause most cases. Research suggests that inherited differences in how the immune system, blood vessels, and clotting systems react to tobacco may affect risk, which may partly explain why the disease is seen more often in some families or populations. For many living with thromboangiitis obliterans, this means genes may influence who gets thromboangiitis obliterans, but tobacco exposure remains the strongest and most preventable trigger. If more than one relative has the condition, doctors usually also look closely at shared smoking habits and other exposures, not genetics alone.
Is Thromboangiitis obliterans genetic?
Genetics do not seem to be a main cause of thromboangiitis obliterans. Some inherited differences may slightly affect risk, but smoking and tobacco exposure are far more important. Family patterns are uncommon, and there is no single known gene test for thromboangiitis obliterans.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are common and are a normal part of human biology. Most do not directly affect health and simply represent natural differences between people. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many people with thromboangiitis obliterans, also known medically as Buerger disease, the biggest treatment issue is protecting blood flow to the hands and feet and preventing new painful flare-ups. Research suggests inherited traits may help explain why some people are more likely to develop the disease or react more strongly to tobacco, but no widely used genetic test can reliably pick the best medicine for thromboangiitis obliterans. Not every difference in response is genetic, but the most effective part of treatment is still complete avoidance of tobacco and nicotine. Doctors usually choose medicines such as drugs that widen blood vessels or ease pain based on symptoms, circulation, wound healing, and possible side effects rather than a standard genetic result. If you are looking into how genetics affect treatment for thromboangiitis obliterans, the current answer is fairly limited: genes may shape risk and sometimes how your body handles certain medicines, but they do not yet guide routine treatment the way they do for some other conditions.
Interactions with other conditions
For many living with thromboangiitis obliterans, smoking-related vessel damage can make leg, foot, hand, or finger symptoms harder to manage, especially if they also have diabetes, high cholesterol, or peripheral artery disease from atherosclerosis. Having more than one diagnosis can make symptoms feel harder to untangle, because poor circulation from another blood vessel problem can add to pain, numbness, slow wound healing, or ulcers. In everyday life, this may look like a sore on a toe that is slow to heal, while it is not always clear whether thromboangiitis obliterans, diabetes, or both are playing the bigger role. Autoimmune and inflammatory illnesses can also complicate the picture, since they may cause some similar circulation symptoms and may need different treatment. Early symptoms of thromboangiitis obliterans can sometimes overlap with nerve problems, blood clotting disorders, or other causes of cold, discolored fingers and toes, so careful diagnosis matters. Talk with your doctor about how your conditions may influence each other, especially because medicines, wound care needs, and the most important step, fully stopping tobacco and nicotine, may be affected by other health issues.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Thromboangiitis obliterans?
Other conditions that can look like thromboangiitis obliterans include peripheral artery disease, where blood flow is reduced by cholesterol buildup in the arteries, and Raynaud's, which can make fingers or toes turn white, blue, numb, or painful in the cold. Doctors may also consider other disorders that inflame blood vessels, blood clots that suddenly block circulation, and diabetes-related nerve and blood flow problems, since these can also cause hand or foot pain, color changes, ulcers, or slow-healing sores.
History
People living with thromboangiitis obliterans, also called Buerger disease, often hear that it is uncommon and strongly linked with tobacco use, but the condition has been described for well over a century. Earlier doctors noticed a striking pattern: usually younger adults, often heavy smokers, developed painful fingers or toes, color changes in the hands or feet, and sores that did not heal well. What may have looked at first like poor circulation from other causes gradually stood out as its own condition.
In 1908, researchers gave a fuller medical description of thromboangiitis obliterans after studying people with inflamed and blocked blood vessels in the arms and legs. At the time, doctors were still sorting out how it differed from hardening of the arteries, which is more common in older adults. That mattered in daily life, because the early symptoms of thromboangiitis obliterans could be easy to dismiss at first, such as foot pain while walking to work, fingertips turning pale in the cold, or a small sore on a toe that lingered.
As medical science evolved, doctors became better at recognizing that thromboangiitis obliterans affects small and medium-sized blood vessels and tends to occur in a particular clinical pattern. Over time, the condition was reported in many parts of the world, especially in places where smoking rates were high. This helped move it from being seen as a medical curiosity to a well-recognized cause of serious circulation problems in some smokers.
The history of thromboangiitis obliterans also reflects changing habits and changing awareness. For many years, it was reported much more often in men, but as tobacco use changed across populations, doctors began seeing it in women as well. Better imaging and pathology studies later confirmed what earlier clinicians suspected: this was not simply ordinary artery disease showing up early, but a distinct inflammatory disorder of blood vessels.
More recently, research has focused on why some smokers develop thromboangiitis obliterans while many do not, and on the roles of immune responses and other biological factors. Although researchers later identified a genetic contribution in some cases, the strongest and most consistent link in its history has remained tobacco exposure. Knowing this history helps explain why stopping all tobacco and nicotine products is still the most important step in care today.